"Kv1.3 Potassium Channel" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A delayed rectifier subtype of shaker potassium channels that is the predominant VOLTAGE-GATED POTASSIUM CHANNEL of T-LYMPHOCYTES.
| Descriptor ID |
D051664
|
| MeSH Number(s) |
D12.776.157.530.400.600.900.500.217 D12.776.543.550.450.750.900.124.358 D12.776.543.585.400.750.900.624.217
|
| Concept/Terms |
Kv1.3 Potassium Channel- Kv1.3 Potassium Channel
- Potassium Channel, Kv1.3
- KCNA3 Potassium Channel
- Potassium Channel, KCNA3
|
Below are MeSH descriptors whose meaning is more general than "Kv1.3 Potassium Channel".
Below are MeSH descriptors whose meaning is more specific than "Kv1.3 Potassium Channel".
This graph shows the total number of publications written about "Kv1.3 Potassium Channel" by people in this website by year, and whether "Kv1.3 Potassium Channel" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2017 | 1 | 1 | 2 |
To return to the timeline, click here.
Below are the most recent publications written about "Kv1.3 Potassium Channel" by people in Profiles.
-
Targeting lymphocyte Kv1.3-channels to suppress cytokine storm in severe COVID-19: Can it be a novel therapeutic strategy? Drug Discov Ther. 2020 Jul 15; 14(3):143-144.
-
Treating autoimmune disorders with venom-derived peptides. Expert Opin Biol Ther. 2017 09; 17(9):1065-1075.
-
Direct Pharmacological Targeting of a Mitochondrial Ion Channel Selectively Kills Tumor Cells In Vivo. Cancer Cell. 2017 04 10; 31(4):516-531.e10.